110
Participants
Start Date
March 31, 2015
Primary Completion Date
March 31, 2016
Study Completion Date
June 30, 2016
Enoxaparin
Enrolled patients will receive real-time monitoring of peak and trough steady state anti-Xa levels. Out-of-range patients will receive real time dose adjustment of Enoxaparin using a clinical protocol developed with our inpatient pharmacists.
University of Utah, Salt Lake City
University of Utah
OTHER